MDL | MFCD00220969 |
---|---|
Molecular Weight | 295.18 |
Molecular Formula | C11H7F6N3 |
SMILES | NC1=CC=C(N2N=C(C(F)(F)F)C=C2C(F)(F)F)C=C1 |
CRAC intermediate 2 is a intermediate compound for CRAC inhibitor synthesis, extracted from patent WO 2013059666A1.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : ≥ 52 mg/mL ( 176.16 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.3878 mL | 16.9388 mL | 33.8776 mL |
5 mM | 0.6776 mL | 3.3878 mL | 6.7755 mL |
10 mM | 0.3388 mL | 1.6939 mL | 3.3878 mL |